Critical evaluation of the MitraClip system in the management of mitral regurgitation

Florian Deuschl; Niklas Schofer; Edith Lubos; Stefan Blankenberg; Ulrich Schäfer

doi:10.2147/VHRM.S65185

Critical evaluation of the MitraClip system in the management of mitral regurgitation

Standard

Critical evaluation of the MitraClip system in the management of mitral regurgitation. / Deuschl, Florian; Schofer, Niklas ; Lubos, Edith ; Blankenberg, Stefan; Schäfer, Ulrich.

in: VASC HEALTH RISK MAN, Jahrgang 12, 2016, S. 1-8.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Deuschl, F, Schofer, N , Lubos, E , Blankenberg, S & Schäfer, U 2016, 'Critical evaluation of the MitraClip system in the management of mitral regurgitation', VASC HEALTH RISK MAN, Jg. 12, S. 1-8. https://doi.org/10.2147/VHRM.S65185

APA

Deuschl, F., Schofer, N., Lubos, E., Blankenberg, S., & Schäfer, U. (2016). Critical evaluation of the MitraClip system in the management of mitral regurgitation. VASC HEALTH RISK MAN, 12, 1-8. https://doi.org/10.2147/VHRM.S65185

Vancouver

Deuschl F, Schofer N , Lubos E , Blankenberg S, Schäfer U. Critical evaluation of the MitraClip system in the management of mitral regurgitation. VASC HEALTH RISK MAN. 2016;12:1-8. https://doi.org/10.2147/VHRM.S65185

Bibtex

@article{60c45382e1db42b3b0fea949491bc999,

title = "Critical evaluation of the MitraClip system in the management of mitral regurgitation",

abstract = "The MitraClip (MC) system is a device for percutaneous, transseptal edge-to-edge reconstruction of the mitral valve (MV) in patients with severe mitral regurgitation (MR) not eligible for surgery. Recently, a number of studies have underlined the therapeutic benefit of the MC system for patients with extreme and high risk for MV surgery suffering from either degenerative or functional MR. The MC procedure shows negligible intraprocedural mortality, low periprocedural complication rates, and a significant reduction in MR, as well as an improvement in functional capacity and most importantly quality of life. Presently, the MC system has become an additional interventional tool in the concert of surgical methods. It hereby enlarges the spectrum of MV repair for the Heart Team. Lately, many reviews focused on the MC system. The current review describes the developments in the treatment of MR with the MC system.",

keywords = "Cardiac Catheterization/adverse effects, Equipment Design, Humans, Mitral Valve/physiopathology, Mitral Valve Insufficiency/diagnosis, Quality of Life, Recovery of Function, Risk Factors, Severity of Illness Index, Treatment Outcome",

author = "Florian Deuschl and Niklas Schofer and Edith Lubos and Stefan Blankenberg and Ulrich Sch{\"a}fer",

year = "2016",

doi = "10.2147/VHRM.S65185",

language = "English",

volume = "12",

pages = "1--8",

journal = "VASC HEALTH RISK MAN",

issn = "1176-6344",

publisher = "DOVE MEDICAL PRESS LTD",

}

RIS

TY - JOUR

T1 - Critical evaluation of the MitraClip system in the management of mitral regurgitation

AU - Deuschl, Florian

AU - Schofer, Niklas

AU - Lubos, Edith

AU - Blankenberg, Stefan

AU - Schäfer, Ulrich

PY - 2016

Y1 - 2016

N2 - The MitraClip (MC) system is a device for percutaneous, transseptal edge-to-edge reconstruction of the mitral valve (MV) in patients with severe mitral regurgitation (MR) not eligible for surgery. Recently, a number of studies have underlined the therapeutic benefit of the MC system for patients with extreme and high risk for MV surgery suffering from either degenerative or functional MR. The MC procedure shows negligible intraprocedural mortality, low periprocedural complication rates, and a significant reduction in MR, as well as an improvement in functional capacity and most importantly quality of life. Presently, the MC system has become an additional interventional tool in the concert of surgical methods. It hereby enlarges the spectrum of MV repair for the Heart Team. Lately, many reviews focused on the MC system. The current review describes the developments in the treatment of MR with the MC system.

AB - The MitraClip (MC) system is a device for percutaneous, transseptal edge-to-edge reconstruction of the mitral valve (MV) in patients with severe mitral regurgitation (MR) not eligible for surgery. Recently, a number of studies have underlined the therapeutic benefit of the MC system for patients with extreme and high risk for MV surgery suffering from either degenerative or functional MR. The MC procedure shows negligible intraprocedural mortality, low periprocedural complication rates, and a significant reduction in MR, as well as an improvement in functional capacity and most importantly quality of life. Presently, the MC system has become an additional interventional tool in the concert of surgical methods. It hereby enlarges the spectrum of MV repair for the Heart Team. Lately, many reviews focused on the MC system. The current review describes the developments in the treatment of MR with the MC system.

KW - Cardiac Catheterization/adverse effects

KW - Equipment Design

KW - Humans

KW - Mitral Valve/physiopathology

KW - Mitral Valve Insufficiency/diagnosis

KW - Quality of Life

KW - Recovery of Function

KW - Risk Factors

KW - Severity of Illness Index

KW - Treatment Outcome

U2 - 10.2147/VHRM.S65185

DO - 10.2147/VHRM.S65185

M3 - SCORING: Review article

C2 - 26811687

VL - 12

SP - 1

EP - 8

JO - VASC HEALTH RISK MAN

JF - VASC HEALTH RISK MAN

SN - 1176-6344

ER -